Cheng, Mandy I. http://orcid.org/0000-0002-8915-0296
Li, Joey H.
Riggan, Luke
Chen, Bryan http://orcid.org/0000-0003-0046-2283
Tafti, Rana Yakhshi
Chin, Scott
Ma, Feiyang http://orcid.org/0000-0002-6260-0787
Pellegrini, Matteo
Hrncir, Haley
Arnold, Arthur P.
O’Sullivan, Timothy E. http://orcid.org/0000-0003-1435-8188
Su, Maureen A. http://orcid.org/0000-0002-3680-9982
Article History
Received: 27 April 2022
Accepted: 14 February 2023
First Online: 16 March 2023
Competing interests
: T.E.O. is a scientific advisor for Modulus Therapeutics and Xyphos companies that have financial interest in human NK cell-based therapeutics. The other authors declare no competing interests.
Free to read: This content has been made available to all.